Drug Relief v1— 510(k) K221231

Substantially Equivalent

Dyansys, Inc.

FDA 510(k) clearance K221231 for Drug Relief v1, Substantially Equivalent on 2022-06-06. Applicant: Dyansys, Inc..

Clearance details

Applicant
Dyansys, Inc.
Product code
Code PZR
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
San Mateo, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.